Product Information
ARIPIPRAZOLE 2 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1146 per EA under NDC 33342012207. Its NADAC has been published 486 times since Jun 14, 2017.
FDA first approved this application on Oct 7, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342012207
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA204111FDA Approved
10/7/2016
TE Code
AB
On Market Since
10/8/2016
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 2 MG TABLET has been published 486 times since Jun 14, 2017, and over the history we have for it it has declined 89.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1146 per EA |
|---|---|
| All-time high | $1.0850 (Jun 14, 2017) |
| All-time low | $0.1014 (Nov 20, 2024) |
| 52-week high | $0.1246 |
| 52-week low | $0.1026 |
| Median price | $0.1475 |
| Average price | $0.2322 |
| Largest weekly change | +33.3% (Aug 21, 2024) |
| Weeks tracked | 486 |
| Tracking since | Jun 14, 2017 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aripiprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 2 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.1146 per EA (NDC 33342012207), effective Sep 30, 2026.
How has the price of ARIPIPRAZOLE 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 2 MG TABLET has declined 89.4%. It has been tracked across 486 weekly CMS publications since Jun 14, 2017.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 2 MG TABLET?
Since Jun 14, 2017, the NADAC for ARIPIPRAZOLE 2 MG TABLET has ranged from a low of $0.1014 (Nov 20, 2024) to a high of $1.0850 (Jun 14, 2017), with a median of $0.1475 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 2 MG TABLET?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ARIPIPRAZOLE 2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 2 MG TABLET?
ARIPIPRAZOLE 2 MG TABLET (NDC 33342012207) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.